Back to news
Avicanna Reports Q1 2025 Results and First Profitable Quarter
@Source: financialpost.com
Medical Cannabis formulary (RHO Phyto™): The formulary offers a diverse range of proprietary products including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids, supported by ongoing patient and medical community education. RHO Phyto is an established brand in Canada currently available nationwide across several channels and expanding into new international markets.
Medical cannabis care platform (MyMedi.ca): MyMedi.ca is a medical cannabis care platform formed with the aim to better serve medical cannabis patients’ needs and enhance the medical cannabis patients’ journey. MyMedi.ca is operated by Northern Green Canada Inc. and features a diverse portfolio of products and bilingual pharmacist-led patient support programs. MyMedi.ca also provides specialty services to distinct patient groups such as veterans and collaborates with public and private payers for adjudication and reimbursement. MyMedi.ca provides educational resources to the medical community to facilitate the incorporation of medical cannabis into health care regimens.
Pharmaceutical pipeline: Leveraging Avicanna’s scientific platform, vertical integration, and real-world evidence, Avicanna has developed a pipeline of proprietary, indication-specific cannabinoid-based candidates that are in various stages of clinical development. These cannabinoid-based candidates aim to address unmet needs in the areas of dermatology, chronic pain, and various neurological disorders.
Active pharmaceutical ingredients (Aureus Santa Marta™): Active pharmaceutical ingredients supplied by the Company’s majority owned subsidiary Santa Marta Golden Hemp SAS (“SMGH”) is a commercial-stage business dedicated to providing various forms of high-quality CBD, THC and CBG to the Company’s international partners for use in the development and production of food, cosmetics, medical, and pharmaceutical products. SMGH also forms part of the Company’s supply chain and is a source of reliable input products for its consumer retail, medical cannabis, and pharmaceutical products globally.
Related News
24 Apr, 2025
Bay County prep roundup: Pitch perfect d . . .
08 May, 2025
British and Irish Lions Squad 2025: The . . .
01 Apr, 2025
Tragic Cause of Death for Yankees Icon B . . .
27 Mar, 2025
Alysa Liu Stuns Field To Lead ISU World . . .
24 May, 2025
Cristiano Ronaldo’s Rough Night: Missed . . .
09 Apr, 2025
Man pleads guilty in plot to assassinate . . .
17 Apr, 2025
Turkey Says Over 175,000 Syrians Return . . .
30 Apr, 2025
Sports News | Madrid Open Players Took B . . .